The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 46
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte INDER M. VERMA, and
DANIEL C. ST. LOUIS
__________
Appeal No. 2000-1930
Application No. 08/232,452
__________
ON BRIEF
__________
Before ADAMS, GRIMES, and GREEN, Administrative Patent Judges.
GREEN, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. § 134 from the examiner’s
final rejection of claims 21-36. Claims 21, 29 and 30 are representative of the
subject matter on appeal, and read as follows:
21. A gene therapy method comprising:
implanting in the loose connective tissue of the dermis of a
subject, a collagen matrix containing transduced subject-derived
primary fibroblasts, wherein said transduced fibroblasts are
infected with a recombinant retroviral vector that comprises
exogenous genetic material encoding a gene product, and wherein
said transduced fibroblasts express said gene product.
Page: 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007